BromSite Approval History
FDA Approved: Yes (First approved April 8, 2016)
Brand name: BromSite
Generic name: bromfenac
Dosage form: Ophthalmic Solution
Company: Sun Pharmaceutical Industries Inc.
Treatment for: Postoperative Ocular Inflammation
BromSite (bromfenac) is a low dose nonsteroidal anti-inflammatory drug (NSAID) ophthalmic solution for the treatment of inflammation and prevention of pain in patients undergoing cataract surgery.